Articles

MK-0457 active against T315I mutation in CML ALL and JAK2 mutation in MPD

Posted on Friday, December 12, 2008 - 12:14pm

Drug Shown To Be Clinically Active Against Multiple Target Mutations In Two Types Of Leukemia And Myeloproliferative Disorders ScienceDaily (Dec. 21, 2006) — Researchers at The University of Texas M. D. Anderson Cancer...

Read more

Vaccine Improves Event-free Survival For Leukemia Patients

Posted on Friday, December 12, 2008 - 12:07pm

Vaccine Improves Event-free Survival For Leukemia Patients ScienceDaily (Dec. 11, 2007) — Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three...

Read more

Dasatinib and nilotinib show strong early results as frontline therapy for CML.

Posted on Friday, December 12, 2008 - 12:03pm

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For Chronic Myelogenous Leukemia ScienceDaily (Dec. 10, 2007) — Two drugs approved for use as second line therapy for chronic myelogenous leukemia are...

Read more

House of Commons-Hansard Debates Nov. 4th 08- NHS Patients (Access to Medicines)

Posted on Friday, November 28, 2008 - 11:50am

4 Nov 2008 : Column 131 NHS Patients (Access to Medicines) 4.7 pm

Read more

EUTOS- European Treatment Outcome Study

Posted on Wednesday, November 26, 2008 - 7:56pm

EUTOS.

Read more

Combating Progressive Disease by Monitoring and Early Detection: War and PCR

Posted on Sunday, November 9, 2008 - 1:51pm

NCCN 3rd Annual Congress: Hematologic Malignancies -- Chronic Myelogenous Leukemia Combating Progressive Disease by Monitoring and Early Detection: War and PCR (Slides with Transcript) Jerald P. Radich, MD...

Read more

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanis

Posted on Friday, November 7, 2008 - 4:52pm

1: Leukemia. 2008 Jun;22(6):1191-9. Epub 2008 Apr 3. Links

Read more

3rd Generation Inhibitors in Development-AP24534, VX-680 (MK-0457), PHA-739358, PPY-A, XL-228, SGX-70393, FTY720 and TG101113

Posted on Thursday, October 30, 2008 - 12:47pm

Curr Top Med Chem. 2008 ;8 (10):905-21 18673174 (P,S,G,E,B) Inhibitors of ABL and the ABL-T315I Mutation.

Read more

Newly Diagnosed? Would you like to participate in a Clinical Research Study of a new treatment for CML?

Posted on Friday, October 24, 2008 - 12:24pm

Have you recently been diagnosed with Chronic Myelogenous Leukaemia (CML)?

Read more

M. D. Anderson - Leukemia Insights Newsletter Volume 13, No. 2 Fall 2008

Posted on Friday, October 10, 2008 - 2:35pm

M. D. Anderson

Read more

Bone-marrow - epetition response

Posted on Tuesday, September 30, 2008 - 5:15pm

Read the Government’s response Adrian Sudbury was a true hero whose selflessness and courage made him an inspiration to all who knew him and many who didn’t. The Prime Minister was pleased to be able to meet Adrian, and...

Read more